Contract Manufacturing, In-Vitro and Licensing

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Contract Manufacturing

In-Vitro

Licensing

Pfizer to supply UNICEF up to 4 million treatment courses of novel COVID-19 oral treatment for low- and middle-income countries

The Pharma Data

MARCH 22, 2022

Pfizer continues to invest to support the manufacturing and distribution of PAXLOVID, including exploring potential contract manufacturing options. Financial details of the agreement were not disclosed. High and upper-middle income countries will pay more than lower income countries.

In-Vitro

In-Vitro Contract Manufacturing Manufacturing Production

PFIZER REPORTS STRONG FIRST-QUARTER 2021 RESULTS

The Pharma Data

MAY 4, 2021

Billion Doses Expected to be Delivered in 2021 Under Signed Contracts as of Mid-April 2021. Enters Into Contracts to Supply BNT162b2 to Canada and Israel for Periods Beyond 2021; Currently Negotiating Similar Potential Contracts with Multiple Other Countries. Raises Full-Year 2021 Guidance (3) for Revenues to a Range of $70.5

Vaccination

Vaccination Vaccine Production Sales

Clinical Research Informer

Pfizer to supply UNICEF up to 4 million treatment courses of novel COVID-19 oral treatment for low- and middle-income countries

PFIZER REPORTS STRONG FIRST-QUARTER 2021 RESULTS

Stay Connected